Positron emission tomography with 2-deoxy-2-[18F] fluoro-D-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion

Journal of Gastroenterology

Volumn 38, Issue 12, 2003, Pages 1189-1193

  Yoshioka, Masato ^a   Sato, Tsutomu ^a   Furuya, Tomoki ^b   Shibata, Satoshi ^a   Andoh, Hideaki ^a   Asanuma, Yoshihiro ^a   Hatazawa, Jun ^c   Koyama, Kenji ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Akita City Hosp   (Japan)

^c RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

Differential diagnosis; FDG PET; IPMT

Indexed keywords

2 DEOXY 2 FLUOROMANNOSE F 18; FLUOROURACIL; MITOMYCIN C;

ABDOMINAL ANGIOGRAPHY; ADULT; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1642544686     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1230-8     Document Type: Article

References (10)

1. Delbeke D. Oncological applications of FDG-PET imaging. J Nucl Med 1999;40:1706-15.
2. Berberat P, Freiss H, Kashiwagi M, Berger HG, Büchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999;23:882-7.
3. Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 2001;234:675-80.
4. Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, Rickaert F, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95: 441-5.
5. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 1998;228:685-91.
6. Obara T, Maguchi H, Saitoh Y, Sohma M, Tsuji K, Koike Y, et al. Intraductal papillary neoplasms of the pancreas: diagnosis by endoscopic pancreatic biopsy. Endoscopy 1993;25:290-3.
7. Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372-7.
8. Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999;134: 1131-6.
9. Kubo H, Chijiiwa Y, Akahoshi K, Hamada S, Harada N, Sumii T, et al. Intraductal papillary-mucinous tumors of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol 2001;96:1429-34.
10. Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002;236:137-48.